MaxCyte, Inc. (AIM:MXCT)
London
· Delayed Price · Currency is GBP · Price in GBX 193.00
-2.00 (-1.03%)
Apr 17, 2025, 4:39 PM GMT+1
MaxCyte Market Cap
MaxCyte has a market cap or net worth of 205.19 million as of April 17, 2025. Its market cap has decreased by -40.44% in one year.
Market Cap
205.19M
Enterprise Value
96.19M
Revenue
30.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
193.00
Market Cap Chart
Since March 29, 2016, MaxCyte's market cap has increased from 33.25M to 205.19M, an increase of 517.01%. That is a compound annual growth rate of 22.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 159.41B |
| GSK plc | 54.59B |
| Haleon | 34.17B |
| Smith & Nephew | 8.68B |
| ConvaTec Group | 5.29B |
| Hikma Pharmaceuticals | 4.20B |
| HUTCHMED (China) | 1.86B |
| Oxford Nanopore Technologies | 1.19B |